People Who Get Johnson & Johnson Vaccine at Elevated Risk of Guillain-Barré Syndrome: Study - The Epoch Times

People who receive the Johnson & Johnson COVID-19 vaccine are at elevated risk of getting a severe autoimmune disorder that can cause paralysis, according to a new study.

A study published in the Journal of the American Medical Association in October, analyzing data from the system, found a “potential small but statistically significant safety concern for Guillain-Barré syndrome following receipt” of the Johnson & Johnson vaccine.

Johnson & Johnson urged people to seek immediate medical attention if any of the following symptoms develop after getting the vaccine: Weakness or tingling sensations, especially in the legs or arms, that’s worsening and spreading to other parts of the body; difficulty walking; difficulty with facial movements, including speaking, chewing, or swallowing; double vision or inability to move eyes; difficulty with bladder control or bowel function.

The Food and Drug Administration in July added a label to Johnson & Johnson’s vaccine warning people about its link to an “observed increased risk” of GBS.